<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The dilute Russell viper venom time and kaolin clotting time (KCT) are very sensitive screening tests for <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> activity </plain></SENT>
<SENT sid="1" pm="."><plain>However, due to the high turbidity of the kaolin reagent it is difficult to accommodate the KCT on the optical end point automation of today </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated five recently reported screening tests (the <z:chebi fb="48" ids="30563">silica</z:chebi> clotting time, the Textarin/Ecarin ratio, the Taipan venom time, the factor V ratio, and a kaolin clotting time using low-turbidity kaolin) as potential alternatives to the KCT </plain></SENT>
<SENT sid="3" pm="."><plain>The sensitivity and specificity of the <z:chebi fb="48" ids="30563">silica</z:chebi> clotting time compared well to KCT, detecting 10/12 KCT positive samples and showing equal sensitivity to dilution of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> positive plasma </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, the <z:chebi fb="48" ids="30563">silica</z:chebi> clotting time allows for a confirmatory <z:chebi fb="0" ids="16247">phospholipid</z:chebi> correction procedure </plain></SENT>
<SENT sid="5" pm="."><plain>False-positive results were seen in 2 of 15 warfarinised samples </plain></SENT>
<SENT sid="6" pm="."><plain>A second assay utilising the ratio of extrinsic/intrinsic factor V assays was not affected by either <z:chebi fb="8" ids="10033">warfarin</z:chebi> or <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>This assay also gave positive results with 3 of 23 samples previously screened as <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> negative but exhibiting anticardiolipin positivity </plain></SENT>
<SENT sid="8" pm="."><plain>It was therefore concluded that a combination of the <z:chebi fb="48" ids="30563">silica</z:chebi> clotting time and dilute Russell viper venom time met the requirements of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> sensitivity with demonstration of <z:chebi fb="0" ids="16247">phospholipid</z:chebi> dependence and optical end point compatibility </plain></SENT>
<SENT sid="9" pm="."><plain>The factor V ratio is a useful second-line screen for both anticoagulated patients and anticardiolipin antibody-positive samples </plain></SENT>
</text></document>